COVID-19 Vaccine Impact on Digital Breast Tomosynthesis Market Opportunities To Reach $3.89 Billion By 2026

Digital Breast Tomosynthesis Market Growth & Trends

The global digital breast tomosynthesis market size is expected to reach USD 3.89 billion by 2026 registering a CAGR of 13.5%, according to a new report by Grand View Research, Inc. Rising awareness about the use of DBT, increasing prevalence of breast cancer, and introduction of technologically advanced products are the key driving factors for the market.

As per the Susan G Komen Breast Cancer Foundation Inc., in 2019, around 41,760 new cases of breast cancer will be reported. In addition, as per the data published in South African Journal of Radiology in 2018, breast cancer is one of the most common cancer type and is one of the leading causes of death in South Africa. Such factors are anticipated to drive the market over the forecast period.

Favorable reimbursement policies are also anticipated to boost the market growth. For instance, Brazilian Ministry of Health has given recommendations for tomosynthesis for the screening of breast cancer. Furthermore, several advantages of DBT are also expected to increase the product demand. For instance, as per the Breast Cancer Organization, after getting the U.S. Food and Drug Administration (FDA) approval, 3D breast tomosynthesis systems are witnessing higher demand than 2D systems.

Request a free sample copy or view report summary: 
Digital Breast Tomosynthesis Market Report

Digital Breast Tomosynthesis Market Report Highlights

• In terms of revenue, standalone 3D systems segment held the largest share in 2018 owing to high prevalence of breast cancer across the globe
• Diagnostics centers segment is expected to witness the fastest CAGR over the forecast period owing to increasing awareness about DBT in both developed and developing countries
• Asia Pacific is expected to be the fastest-growing regional market over the forecast period owing to the introduction of technologically advanced products
• Prominent companies in the global digital breast tomosynthesis market are Hologic, Inc.; GE Healthcare; Siemens Healthineers; Dexela Ltd.; and Fujifilm Corporation